|
|
Learning Objectives for this Presentation:
By the end of the presentation participants will be able to:
1. Understand how to conduct gaps analysis activities to assess PCP knowledge and barriers to HCV standards of care.
2. Identify barriers to risk assessment, screening and diagnosis of patients at risk for HCV.
3. Learn how gaps analysis activities inform the development of provider educational initiatives and tools.
Background:
Approximately 85% of the 2.7 million Americans chronically infected with hepatitis C virus (HCV), are unaware of their diagnosis. This suggests that HCV is grossly under diagnosed. Studies show that HCV testing by primary care physicians (PCP) is seldom initiated. Most PCPs are not aware of the risk behaviors associated with HCV, and lack knowledge on how to assess and diagnose it. The aim of this program is to identify PCP barriers to risk assessment and testing in order to increase rates of screening and diagnosis of HCV.
Methods:
The NYSDOH, Bureau of Communicable Disease Control and the Foundation for Healthy Living (FHL) are conducting a series of focus groups statewide to examine PCP knowledge, barriers and training needs as they relate to HCV assessment, screening and treatment. A Physician Focus Group Survey was developed and administered to providers in a group setting. Results from three physician focus groups and other needs assessment and gaps analysis activities will be presented.
Results:
Initial feedback showed several perceived systems barriers to risk assessment and screening. The most noted barriers were lack of time, inconsistent medical history updates and knowledge about who is at risk. Among other barriers, comfudsion about screening and testing options were identified.
Conclusions:
The development of clear-cut guidelines, simple risk assessment tools, screening algorithms and CME initiatives are expected to assist providers in identifying patients at risk for HCV to institute appropriate diagnostic testing, referral and counseling interventions.
See more of Poster Session #2
See more of The 2005 National Viral Hepatitis Prevention Conference